Zymeworks Appoints Kristin Stafford as Chief Financial Officer
Zymeworks Inc., a Nasdaq-listed biotechnology company, has appointed Kristin Stafford as its Chief Financial Officer effective April 1, 2026. Stafford brings extensive life sciences industry experience and a strong background in strategic planning, capital allocation, and complex financial transactions. Her addition is expected to support Zymeworks…